Body Vision Medical (בודיויז'ן מדיקל)

Body Vision Medical, a medical device company specializing in augmented real-time imaging, has developed the Body Vision Solution, a software-driven intra-body navigation platform. Designed to integrate seamlessly into the flow of existing operating room procedures, Body Vision provides accurate, real-time visualization, navigation, and tools to access soft-tissue targets such as early-stage cancerous lesions during diagnostic and treatment procedures. Body Vision Medical's platform technology allows reliable diagnostic and treatment procedures for radiolucent soft-tissue lesions. The company's software, hardware, and disposable tools help surgeons plan, visualize, and track their navigation during these procedures.Body Vision received FDA clearance for its LungVision System in 2017 and for the LungVision Disposable Tool in 2018. In May 2019, the company received FDA clearance to market the LungVision 2.0, part of the LungVision Platform System. The company has completed 400 clinical procedures as of October 2019.

66.7
66.7
NaN
NaN
NaN
NaN
Links
Valuation
$
Funding
$ 20.00 M
$ 34.50 M
Statistics
NA

Body Vision Medical, a medical device company specializing in augmented real-time imaging, has developed the Body Vision Solution, a software-driven intra-body navigation platform. Designed to integrate seamlessly into the flow of existing operating room procedures, Body Vision provides accurate, real-time visualization, navigation, and tools to access soft-tissue targets such as early-stage cancerous lesions during diagnostic and treatment procedures. Body Vision Medical's platform technology allows reliable diagnostic and treatment procedures for radiolucent soft-tissue lesions. The company's software, hardware, and disposable tools help surgeons plan, visualize, and track their navigation during these procedures.Body Vision received FDA clearance for its LungVision System in 2017 and for the LungVision Disposable Tool in 2018. In May 2019, the company received FDA clearance to market the LungVision 2.0, part of the LungVision Platform System. The company has completed 400 clinical procedures as of October 2019.

Overview
Merck KGaAMerck KGaAMerck KGaAMerck KGaAMerck KGaA 
View All
0and0